Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arterius is a UK-based medtech company developing polymer technologies for vascular intervention, with a focus on devices that leave no permanent implant behind. Its core programs include a drug-delivery coating technology designed to transfer one or more drugs into the vessel wall and ArterioSorb, a bioresorbable scaffold intended to support a vessel for several months before resorption. The company currently emphasizes applications in peripheral arterial disease while also describing development of next-generation bioresorbable cardiovascular scaffolds. Arterius appears to be a private, active company headquartered in Leeds, England, and has raised grant and equity funding to advance its technology platforms toward proof of concept.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arterius.